126 related articles for article (PubMed ID: 10984261)
1. Growth hormone therapy for Prader-Willi and Down syndromes: a post-modern medical dilemma.
Lantos JD
Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S93-4. PubMed ID: 10984261
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy in young children with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes.
Annerén G; Tuvemo T; Gustafsson J
Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S87-91. PubMed ID: 10984260
[TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone treatment in children with Prader-Willi syndrome.
Lee PD
Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S75-9. PubMed ID: 10984258
[TBL] [Abstract][Full Text] [Related]
4. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
Schmidt H; Bechtold S; Schwarz HP
Eur J Med Res; 2000 Jul; 5(7):307-10. PubMed ID: 10903191
[TBL] [Abstract][Full Text] [Related]
5. Clinical Indications for Growth Hormone Therapy.
Danowitz M; Grimberg A
Adv Pediatr; 2022 Aug; 69(1):203-217. PubMed ID: 35985710
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
Fillion M; Deal C; Van Vliet G
J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
[TBL] [Abstract][Full Text] [Related]
7. One-year results of growth hormone treatment of short stature in Prader-Willi syndrome.
Hauffa BP
Acta Paediatr Suppl; 1997 Nov; 423():63-5. PubMed ID: 9440907
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.
Donze SH; Kuppens RJ; Bakker NE; van Alfen-van der Velden JAEM; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2018 Jun; 88(6):806-812. PubMed ID: 29418016
[TBL] [Abstract][Full Text] [Related]
9. Effects of 5 years growth hormone treatment in patients with Prader-Willi syndrome.
Obata K; Sakazume S; Yoshino A; Murakami N; Sakuta R
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):155-62. PubMed ID: 12713251
[TBL] [Abstract][Full Text] [Related]
10. Ethical issues in emerging new treatments such as growth hormone therapy for children with Down syndrome and Prader-Willi syndrome.
Kodish E; Cuttler L
Curr Opin Pediatr; 1996 Aug; 8(4):401-5. PubMed ID: 8954275
[TBL] [Abstract][Full Text] [Related]
11. Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement.
Myers SE; Davis A; Whitman BY; Santiago JV; Landt M
Clin Endocrinol (Oxf); 2000 Jan; 52(1):101-5. PubMed ID: 10651760
[TBL] [Abstract][Full Text] [Related]
12. Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Group.
Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
Acta Paediatr Suppl; 1997 Nov; 423():60-2. PubMed ID: 9401542
[TBL] [Abstract][Full Text] [Related]
13. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
Carrel AL; Allen DB
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
[TBL] [Abstract][Full Text] [Related]
14. Diabetic ketoacidosis secondary to growth hormone treatment in a boy with Prader-Willi syndrome and steatohepatitis.
Yigit S; Estrada E; Bucci K; Hyams J; Rosengren S
J Pediatr Endocrinol Metab; 2004 Mar; 17(3):361-4. PubMed ID: 15112913
[TBL] [Abstract][Full Text] [Related]
15. Sudden death in Prader-Willi syndrome during growth hormone therapy.
Sacco M; Di Giorgio G
Horm Res; 2005; 63(1):29-32. PubMed ID: 15583479
[TBL] [Abstract][Full Text] [Related]
16. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Ritzén EM
Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
[TBL] [Abstract][Full Text] [Related]
17. [Prader-Labhart-Willi syndrome].
Fesseler WH; Bierich JR
Monatsschr Kinderheilkd; 1983 Dec; 131(12):844-7. PubMed ID: 6664356
[TBL] [Abstract][Full Text] [Related]
18. [Prader-Willi syndrome: A case report].
Ma HW; Dai XM
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):521-3. PubMed ID: 17178054
[No Abstract] [Full Text] [Related]
19. Maladaptive behavior in children with Prader-Willi syndrome, Down syndrome, and nonspecific mental retardation.
Dykens EM; Kasari C
Am J Ment Retard; 1997 Nov; 102(3):228-37. PubMed ID: 9394132
[TBL] [Abstract][Full Text] [Related]
20. Linear growth response to exogenous growth hormone in Prader-Willi syndrome.
Lee PD; Wilson DM; Rountree L; Hintz RL; Rosenfeld RG
Am J Med Genet; 1987 Dec; 28(4):865-71. PubMed ID: 3688024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
